Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
AbbVie
ABBV
|
+$239M |
| 2 |
Otis Worldwide
OTIS
|
+$156M |
| 3 |
Verizon
VZ
|
+$145M |
| 4 |
Baidu
BIDU
|
+$139M |
| 5 |
Carrier Global
CARR
|
+$135M |
Top Sells
| 1 |
Apple
AAPL
|
+$381M |
| 2 |
Amazon
AMZN
|
+$358M |
| 3 |
Bank of America
BAC
|
+$265M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$241M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Spyre Therapeutics
SYRE
$978M
| $4.61M | ﹤0.01% |
19,949
-1,164
| -6% | -$269K |
|
2502
Compañía de Cervecerías Unidas
CCU
$2.24B
| $4.6M | ﹤0.01% |
320,301
-46,712
| -13% | -$671K |
|
|
ZIXI
2503
DELISTED
Zix Corporation
ZIXI
| $4.58M | ﹤0.01% |
663,989
-615,373
| -48% | -$4.25M |
|
|
CLDT
2504
Chatham Lodging
CLDT
$354M
| $4.56M | ﹤0.01% |
745,608
-12,811
| -2% | -$78.4K |
|
|
MAXR
2505
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $4.56M | ﹤0.01% |
253,991
+74,683
| +42% | +$1.34M |
|
2506
KT
KT
$9.67B
| $4.53M | ﹤0.01% |
465,517
-3,800
| -0.8% | -$37K |
|
2507
LCNB Corp
LCNB
$230M
| $4.53M | ﹤0.01% |
284,024
+15,916
| +6% | +$254K |
|
2508
Key Tronic
KTCC
$36.7M
| $4.52M | ﹤0.01% |
860,414
-9,687
| -1% | -$50.9K |
|
2509
Vermilion Energy
VET
$1.14B
| $4.5M | ﹤0.01% |
1,007,858
-13,754
| -1% | -$61.3K |
|
2510
Sabesp
SBS
$16.1B
| $4.49M | ﹤0.01% |
428,153
-234,700
| -35% | -$2.46M |
|
2511
First Northwest Bancorp
FNWB
$63.1M
| $4.49M | ﹤0.01% |
361,155
+5,443
| +2% | +$67.6K |
|
|
SNR
2512
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $4.46M | ﹤0.01% |
1,232,386
+3,712
| +0.3% | +$13.4K |
|
2513
Gyre Therapeutics
GYRE
$738M
| $4.46M | ﹤0.01% |
101,207
-510
| -0.5% | -$22.5K |
|
2514
AstroNova
ALOT
$76.9M
| $4.44M | ﹤0.01% |
558,277
-11,538
| -2% | -$91.8K |
|
|
HBMD
2515
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $4.44M | ﹤0.01% |
418,251
+8,602
| +2% | +$91.4K |
|
|
WBK
2516
DELISTED
Westpac Banking Corporation
WBK
| $4.44M | ﹤0.01% |
354,830
-95,983
| -21% | -$1.2M |
|
|
CBIO
2517
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $4.43M | ﹤0.01% |
11,781
+28
| +0.2% | +$10.5K |
|
|
AFI
2518
DELISTED
Armstrong Flooring, Inc.
AFI
| $4.42M | ﹤0.01% |
1,479,567
-293,102
| -17% | -$876K |
|
2519
Palomar
PLMR
$3.18B
| $4.41M | ﹤0.01% |
+51,440
| New | +$4.41M |
|
2520
First United
FUNC
$239M
| $4.4M | ﹤0.01% |
330,126
-325
| -0.1% | -$4.34K |
|
|
ENZ
2521
DELISTED
Enzo Biochem, Inc.
ENZ
| $4.4M | ﹤0.01% |
1,962,709
-103,656
| -5% | -$232K |
|
|
GOL
2522
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $4.39M | ﹤0.01% |
646,584
-78,904
| -11% | -$535K |
|
2523
AmeriServ Financial
ASRV
$47.1M
| $4.39M | ﹤0.01% |
1,432,852
-17,513
| -1% | -$53.6K |
|
2524
Guaranty Bancshares
GNTY
$559M
| $4.38M | ﹤0.01% |
186,351
+29,037
| +18% | +$683K |
|
|
CSII
2525
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.38M | ﹤0.01% |
138,791
+22,044
| +19% | +$696K |
|